Cargando…

Contrast medium-induced nephropathy, a more practical approach to prevention?

Detalles Bibliográficos
Autores principales:	Rayner, A, Abdulkarim, J, Sterner, G, Nyman, U
Formato:	Texto
Lenguaje:	English
Publicado:	CoAction Publishing 2007
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078242/ https://www.ncbi.nlm.nih.gov/pubmed/21503234 http://dx.doi.org/10.4176/070902

Ejemplares similares

Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention
por: Sterner, Gunnar, et al.
Publicado: (2007)

Is Contrast Medium Osmolality a Causal Factor for Contrast-Induced Nephropathy?
por: Bucher, Andreas M., et al.
Publicado: (2014)

An intriguing relation between atrial fibrillation and contrast-induced nephropathy
por: Ashish, Kumar, et al.
Publicado: (2018)

Evaluation of different sodium bicarbonate regimens for the prevention of contrast medium-induced nephropathy
por: Abouzeid, Sameh, et al.
Publicado: (2016)

Contrast-induced nephropathy: pharmacology, pathophysiology and prevention
por: Geenen, Remy W. F., et al.
Publicado: (2013)

Contrast safety in the cancer patient: preventing contrast-induced nephropathy
por: Heiken, Jay P.
Publicado: (2008)

Effects of Remote Ischemic Pre-Conditioning to Prevent Contrast-Induced Nephropathy after Intravenous Contrast Medium Injection: A Randomized Controlled Trial
por: Belabbas, Dihia, et al.
Publicado: (2020)

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Richter, Sara K., et al.
Publicado: (2015)

Intravenous Contrast Medium Administration for Computed Tomography Scan in Emergency: A Possible Cause of Contrast-Induced Nephropathy
por: Sonhaye, Lantam, et al.
Publicado: (2015)

Contrast-induced Nephropathy
por: Mohammed, Nazar M. A., et al.
Publicado: (2013)

Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
por: Panova, Ina G., et al.
Publicado: (2023)

Preventing contrast-induced nephropathy: problems, challenges and future directions
por: Solomon, Richard
Publicado: (2009)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
por: Bidram, Peyman, et al.
Publicado: (2015)

Prevention of contrast induced nephropathy; a cardiology point of view
por: Hashemi, Mohammad, et al.
Publicado: (2015)

Effects of thymoquinone in prevention of experimental contrast-induced nephropathy in rats
por: Topaloğlu, Ulaş Serkan, et al.
Publicado: (2019)

N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients—focus on the antioxidant and anti-inflammatory properties
por: Cepaityte, Dainora, et al.
Publicado: (2023)

Contrast induced nephropathy in urology
por: Thomson, Viji Samuel, et al.
Publicado: (2009)

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review
por: Sacha, Jerzy, et al.
Publicado: (2019)

Quercetin, a Promising Clinical Candidate for The Prevention of Contrast-Induced Nephropathy
por: Vicente-Vicente, Laura, et al.
Publicado: (2019)

Minimal risk of contrast-induced kidney injury in a randomly selected cohort with mildly reduced GFR
por: Carlqvist, Jeanette, et al.
Publicado: (2020)

N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review
por: Jo, Sang-Ho
Publicado: (2011)

Effect of ligustrazine on preventing contrast-induced nephropathy in patients with unstable angina
por: Ye, Ziliang, et al.
Publicado: (2017)

Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2017)

Contrast Medium Induced Nephropathy after Endovascular Stent Graft Placement: An Examination of Its Prevalence and Risk Factors
por: Kawatani, Yohei, et al.
Publicado: (2016)

Membranous Nephropathy Associated with Tuberculosis
por: Shang, Ming-Hua, et al.
Publicado: (2016)

The Red Back an Essential Medium
Publicado: (1904)

Contrast-induced nephropathy in interventional cardiology
por: Sudarsky, Doron, et al.
Publicado: (2011)

The role of inflammation in contrast-induced nephropathy
por: Kwasa, E A, et al.
Publicado: (2014)

Contrast induced nephropathy; recent findings
por: Mardani, Saeed, et al.
Publicado: (2013)

Silymarin for the Prevention of Contrast-Induced Nephropathy: A Placebo-Controlled Clinical Trial
por: Sedighifard, Zohreh, et al.
Publicado: (2016)

Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency
por: Ye, Ziliang, et al.
Publicado: (2017)

Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
por: Galal, Haitham, et al.
Publicado: (2020)

Bench-to-bedside review: Preventive measures for contrast-induced nephropathy in critically ill patients
por: van den Berk, Guido, et al.
Publicado: (2005)

Identification of Transcription Regulatory Relationships in Diabetic Nephropathy
por: Shi, Jing-Song, et al.
Publicado: (2018)

Comment on “New therapeutic agents in diabetic nephropathy”
por: Gay, Alain, et al.
Publicado: (2017)

COVID-19 Vaccination in Immunoglobulin A Nephropathy
por: Lim, Cynthia Ciwei, et al.
Publicado: (2021)

IgA nephropathy preceded by erythroderma with eosinophilia
por: Takatsu, Mina, et al.
Publicado: (2022)

IgA nephropathy with podocytic infolding glomerulopathy
por: Wang, Zhouyang, et al.
Publicado: (2023)

On the D.E.C. Medium of Panja and Ghosh
por: Felsenfeld, Oscar, et al.
Publicado: (1945)

A More Contextualized Approach: Addressing COVID-19 Vaccine Hesitancy in the Philippines
por: Cordero, Dalmacito A.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ndlm5d1eeqa5tnv58one4f12aa